FDA NDC Directory · JSON-LD · Markdown

Yutrepia

NDC 72964-013 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nametreprostinil
Labeler / ManufacturerLiquidia Technologies, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA213005
Dosage form / routeCAPSULE · RESPIRATORY (INHALATION)
Active ingredientsTREPROSTINIL SODIUM (79.5 ug/1)
Marketing started20250523
Package count1

External sources

Source: openFDA. Public-domain (CC0).